Work

Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer

Year: 2007

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-006-0411-6

Authors: Jeffrey A. Meyerhardt, Jeffrey W. Clark, Jeffrey G. Supko, Joseph P. Eder, Shuji Ogino, Clinton F. Stewart, Ferdinando D’Amato, Janet Dancey, Peter C. Enzinger, Andrew X. Zhu, David P. Ryan, Craig C. Earle, Robert J. Mayer, Ann Michelini, Kate Kinsella, Charles S. Fuchs

Institutions: Dana-Farber Cancer Institute, Harvard University, Massachusetts General Hospital, St. Jude Children's Research Hospital, National Institutes of Health, National Cancer Institute

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G2168052027, Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis

OpenAlex ID: W2001681145

FWCI: 0.949

Cites: 51

Cited by: 26

Related to: 10